treatment with bilastine plus montelukast over 4 weeks does not consistently produce further improvements in SARC symptoms and AQLQ beyond those provided by either agents alone. Thus, there is no benefit of using bilastine plus montelukast to provide relief of SARC symptoms in partially controlled, mild-to-moderate asthma patients

Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study / Lavorini, Federico; Matucci, Andrea; Rossi, Oliviero; Pistolesi, Massimo. - In: ALLERGY. - ISSN 0105-4538. - ELETTRONICO. - (2019), pp. 1-4. [10.1111/all.14007]

Concomitant Bilastine and Montelukast as Additive Therapy for Seasonal Allergic Rhinoconjunctivits and Mild-to-Moderate Asthma. The SKY Study

Lavorini, Federico
;
Matucci, Andrea;ROSSI, OLIVIERO;Pistolesi, Massimo
2019

Abstract

treatment with bilastine plus montelukast over 4 weeks does not consistently produce further improvements in SARC symptoms and AQLQ beyond those provided by either agents alone. Thus, there is no benefit of using bilastine plus montelukast to provide relief of SARC symptoms in partially controlled, mild-to-moderate asthma patients
2019
1
4
Lavorini, Federico; Matucci, Andrea; Rossi, Oliviero; Pistolesi, Massimo
File in questo prodotto:
File Dimensione Formato  
Lavorini_et_al-2019-Allergy.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 196.04 kB
Formato Adobe PDF
196.04 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1169350
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 6
social impact